CRT Capital Initiates Ligand Pharmaceuticals With Buy - Ligand Pharmaceuticals (NASDAQ:LGND)

27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.

CRT Capital initiated coverage on Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) with a Buy rating.The target price for Ligand Pharmaceuticals is set to $102.Ligand Pharmaceuticals shares have dropped 13.54% over the past 52 weeks, while the S&P 500 index has surged 12.99% in the same period.Ligand Pharmaceuticals' shares rose 4.99% to $66.75 in pre-market trading.

27% profits every 20 days?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!